Samuel J. Klempner

Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

Jaffer A. Ajani, Thomas A. D’Amico, David J. Bentrem et al. · Journal of the National Comprehensive Cancer Network · 2022 · 1.7K citations · Full text

Medicine, Molecular Medicine, Oncology +17

Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer

Alexa B. Schrock, Ching Ouyang, Jaideep Sandhu et al. · Annals of Oncology · 2019 · 628 citations

Medicine, Immunology, Oncology +17

Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology

Jaffer A. Ajani, Thomas A. D’Amico, David J. Bentrem et al. · Journal of the National Comprehensive Cancer Network · 2023 · 520 citations · Full text

Medicine, Oncology, Pathology +17

Clinical Acquired Resistance to KRASG12C Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS–MAPK Reactivation

Noritaka Tanaka, Chendi Li, Meagan B. Ryan et al. · Cancer Discovery · 2021 · 517 citations · Full text

Medicine, Oncology, Pharmacology +14

Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated <i>KRAS</i> G12C

Rona Yaeger, Jared Weiss, Meredith Pelster et al. · New England Journal of Medicine · 2022 · 485 citations · Full text

Medicine, Oncology, Pharmacology +16